Aerie Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AERI Nasdaq 2834 http://www.aeriepharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aerie Pharmaceuticals Inc

Aerie Pharmaceuticals Initiates First-in-Human Clinical Trial of AR-13503 Sustained Release Intravitreal Implant in Patients with Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema - Aug 20th, 2019 4:30 am
Zuckerberg Sells Shares of Facebook - Aug 19th, 2019 11:56 am
Edited Transcript of AERI earnings conference call or presentation 7-Aug-19 9:00pm GMT - Aug 11th, 2019 12:58 am
This Biotech Crashed On 'Erroneous' Report — Plus 2 Stocks That Diverged - Aug 8th, 2019 2:08 pm
Aerie (AERI) Beats on Q2 Earnings & Sales, Lowers Guidance - Aug 8th, 2019 7:25 am
Aerie Pharmaceuticals, Inc.'s (NASDAQ:AERI) Path To Profitability - Aug 8th, 2019 7:02 am
Aerie Pharmaceuticals, Inc. (AERI) Q2 2019 Earnings Call Transcript - Aug 7th, 2019 11:50 pm
Aerie Pharmaceuticals (AERI) Reports Q2 Loss, Tops Revenue Estimates - Aug 7th, 2019 4:05 pm
Aerie Pharmaceuticals Reports Second Quarter 2019 Financial Results, Updates Full-Year 2019 Guidance and Provides Business Update - Aug 7th, 2019 2:01 pm
Will Aerie Pharmaceuticals (AERI) Report Negative Earnings Next Week? What You Should Know - Jul 31st, 2019 8:36 am
Analysts Recommend Buying These 2 Falling Knives - Jul 28th, 2019 7:23 pm
Aerie Pharmaceuticals to Announce Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, August 7, 2019 - Jul 25th, 2019 5:30 am
Allergan Announces FDA Acceptance of Glaucoma Candidate NDA - Jul 18th, 2019 4:26 pm
Hatteras Ventures-backed firm adds fresh round of capital - Jul 18th, 2019 6:22 am
How a Durham firm stands to benefit from an unexpected break in a Japanese trial - Jul 11th, 2019 4:46 am
Aerie Completes Enrollment Under Rhopressa Study in Japan - Jul 9th, 2019 3:48 pm
Aerie Pharmaceuticals Completes Enrollment of the Netarsudil Ophthalmic Solution Phase 2 Clinical Trial in Japan Months Ahead of Schedule - Jul 9th, 2019 4:30 am
Ocular (OCUL) Gets FDA Nod for Label Expansion of Dextenza - Jun 24th, 2019 6:50 am
Is Aerie Pharmaceuticals Inc (AERI) A Good Stock To Buy? - Jun 20th, 2019 5:09 pm
See what the IHS Markit Score report has to say about Aerie Pharmaceuticals Inc. - Jun 18th, 2019 6:04 am